16:40 EDT Kezar Life Sciences trading resumes
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KZR:
- Kezar Life Sciences price target raised to $20 from $18 at H.C. Wainwright
- Kezar Life Sciences enters into collaboration pact with Everest Medicines
- Kezar Life Sciences downgraded to Equal Weight from Overweight at Wells Fargo
- Kezar Life Sciences price target lowered to $18 from $19 at H.C. Wainwright
- Kezar Life Sciences reports Q2 EPS (34c), consensus (32c)